| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Previous issue > Previous issue



Table of Contents | June, 2013  Vol. 31  No.2 Previous Issue | Next Issue | Archive
In this issue:


Review Article
Enhancement of radiation effect using beta-lapachone and underlying mechanism
Ki Jung Ahn, Hyung Sik Lee, Se Kyung Bai, Chang Won Song
Radiat Oncol J. 2013;31(2):57-65.   Published online June 30, 2013

Beta-lapachone (β-Lap; 3,4-dihydro-2, 2-dimethyl-2H-naphthol[1, 2-b]pyran-5,6-dione) is a novel anti-cancer drug under phase I/II clinical trials. β-Lap has been demonstrated to cause apoptotic and necrotic death in a variety of human cancer cells in vitro and in vivo. The mechanisms underlying the β-Lap toxicity against cancer cells has been controversial. The most recent view is that β-Lap, which is a quinone...

Original Articles
Clinical Investigation
Long-term results of ipsilateral radiotherapy for tonsil cancer
Tae Ryool Koo, Hong-Gyun Wu
Radiat Oncol J. 2013;31(2):66-71.   Published online June 30, 2013
Purpose

We evaluated the effectiveness and safety of ipsilateral radiotherapy for the patient with well lateralized tonsil cancer: not cross midline and <1 cm of tumor invasion into the soft palate or base of tongue.

Materials and Methods

From 2003 to 2011, twenty patients with well lateralized tonsil cancer underwent ipsilateral radiotherapy. Nineteen patients had T1-T2 tumors, and one patient had T3 tumor;...

The reasonable timing of the adjuvant radiotherapy in the treatment of uterine carcinosarcoma according to the surgical intent: suggestion based on progression patterns
Jeong Il Yu, Doo Ho Choi, Seung Jae Huh, Won Park, Dongryul Oh, Duk Soo Bae
Radiat Oncol J. 2013;31(2):72-80.   Published online June 30, 2013
Purpose

We designed this study to identify and suggest the reasonable timing of adjuvant radiotherapy in the treatment of uterine carcinosarcoma according to the surgical intent and patterns of progression.

Materials and Methods

We retrospectively analyzed a total of 50 carcinosarcoma patients diagnosed between 1995 and 2010. Among these 50 patients, 32 underwent curative surgery and 13 underwent maximal tumor debulking surgery. The...

Endoscopic findings of rectal mucosal damage after pelvic radiotherapy for cervical carcinoma: correlation of rectal mucosal damage with radiation dose and clinical symptoms
Tae Gyu Kim, Seung Jae Huh, Won Park
Radiat Oncol J. 2013;31(2):81-87.   Published online June 30, 2013
Purpose

To describe chronic rectal mucosal damage after pelvic radiotherapy (RT) for cervical cancer and correlate these findings with clinical symptoms and radiation dose.

Materials and Methods

Thirty-two patients who underwent pelvic RT were diagnosed with radiation-induced proctitis based on endoscopy findings. The median follow-up period was 35 months after external beam radiotherapy (EBRT) and intracavitary radiotherapy (ICR). The Vienna Rectoscopy Score (VRS)...

Categorizing accident sequences in the external radiotherapy for risk analysis
Jonghyun Kim
Radiat Oncol J. 2013;31(2):88-96.   Published online June 30, 2013
Purpose

This study identifies accident sequences from the past accidents in order to help the risk analysis application to the external radiotherapy.

Materials and Methods

This study reviews 59 accidental cases in two retrospective safety analyses that have collected the incidents in the external radiotherapy extensively. Two accident analysis reports that accumulated past incidents are investigated to identify accident sequences including initiating events,...

The location of locoregional recurrence in pathologic T3N0, non-irradiated lower rectal cancer
Mi Sun Kim, Ki Chang Keum, Woo Joong Rhee, Hyunju Kim, Minji Kim, Seohee Choi, Ki Chang Nam, Woong Sub Koom
Radiat Oncol J. 2013;31(2):97-103.   Published online June 30, 2013
Purpose

To investigate the patterns of locoregional recurrence of pathologic T3N0 (pT3N0) lower rectal cancer omitting postoperative radiotherapy (RT) and explore the potential of modification of a RT field.

Materials and Methods

From Jan 2003 to Nov 2011, 35 patients omitting preoperative or postoperative RT for pT3N0 lower rectal cancer were included. We defined the lower rectal cancer as the tumor with the...

Physics Contribution
Comparison study of intensity modulated arc therapy using single or multiple arcs to intensity modulated radiation therapy for high-risk prostate cancer
Hani Ashamalla, Ajay Tejwani, Ioannis Parameritis, Uma Swamy, Pei Ching Luo, Adel Guirguis, Amir Lavaf
Radiat Oncol J. 2013;31(2):104-110.   Published online June 30, 2013
Purpose

Intensity modulated arc therapy (IMAT) is a form of intensity modulated radiation therapy (IMRT) that delivers dose in single or multiple arcs. We compared IMRT plans versus single-arc field (1ARC) and multi-arc fields (3ARC) IMAT plans in high-risk prostate cancer.

Materials and Methods

Sixteen patients were studied. Prostate (PTVP), right pelvic (PTVRtLN) and left pelvic lymph nodes (PTVLtLN), and organs at risk...

E-Submission
Principles of Transparency and Best Practice
Author's Index
KOSRO
Journal Impact Factor 1.8
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Editorial Office
Department of Radiation Oncology, Samsung Medical Center,
Proton Therapy Center, B2, 81, Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea
Tel : +82-2-3410-3617
E-mail: rojeditor@gmail.com, roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.                      Developed in M2PI
Close layer
prev next